This news summary is provided by Foley’s Competitive Intelligence Team to inform business leaders of recent news and developments relevant to the Manufacturing Sector.
Analysis by Julie Dautermann, Competitive Intelligence Analyst
Key Developments
- The most recent article in Foley & Lardner’s Supply Chain Disruption Series provides an overview of three key defenses to contractual performance pertaining to force majeure, commercial impracticability and frustration of purpose. Click here to subscribe to the series.
- The National Association of Manufacturers released its Competing to Win policy roadmap addressing a number of the “laws and regulations needed to strengthen the manufacturing industry in the months and years ahead.”
- Sustainability, maintaining resilient supply networks and pursuing opportunities related to smart factories are among the most urgent and important issues facing manufacturing companies in the year ahead, according to the Manufacturing Leadership Council’s new 2022/2023 Critical Issues Agenda.
- Producer prices for final demand goods and services increased 8.7% and consumer prices increased 8.3% on an unadjusted basis for the 12 months ended in August 2022, according to data released last week by the Bureau of Labor Statistics. Between July and August, the Producer Price Index fell by 0.1%, and the Consumer Price Index was up by 0.1%, on a seasonally adjusted basis.
- Bain & Company’s 2022 Technology Report includes analysis on sustainable packaging in consumer goods, the outlook for the chip shortage, circular supply chains for hardware products and expanding implementation capabilities related to the Industrial Internet of Things.
- The National Association of Manufacturers’ Q3 2022 Manufacturers’ Outlook Survey revealed 40.4% of respondents felt inflationary pressures were worse today than six months ago, and 63.3% of manufacturing leaders believe the U.S. economy will enter a recession in 2022 or 2023. In addition, 75.6% of respondents were somewhat or very positive about their company outlook, down from 82.6% in June and reflecting the lowest level since the fourth quarter of 2020.
- A report from DHL and the NYU Stern School of Business predicts global trade will grow “slightly faster” in 2022 and 2023 than it did over the previous decade. Vietnam, India and the Philippines are identified as particular areas of trade growth through 2026 as companies look to diversify production and sourcing.
- The Wall Street Journal reports Western supply chains could become less integrated with China due to laws and proposals in the U.S. and Europe which address products made using forced labor, as well as commitments to increase domestic production. The article also predicts the rapid globalization experienced in the last few decades may “take a pause,” but a full supply chain decoupling from China remains unlikely.
- Railroads and labor unions reached tentative contract agreements last week, averting a potential strike which could have exacerbated supply chain constraints. According to an update from Law360, a number of the unions still need to vote to ratify the agreements.
Smart Manufacturing
- Shipments of industrial robots to China increased 45% in 2021, representing just under half of installations worldwide last year, according to data from the International Federation of Robotics excerpted in The Wall Street Journal. The IFR will release full-year 2021 industrial and service robot sales figures next month.
Supply Chain
- Supply Chain Dive reports a number of major steelmakers are reducing production in response to falling demand, lower average selling prices and elevated raw material costs.
- A recent survey of procurement decision-makers across a range of industries found 68% of respondents view suppliers as a source of differentiation, 66% collaborate with suppliers to increase supply resilience, and 51% plan to collaborate with more suppliers. In addition, 75% of respondents include their suppliers in medium-term planning and 73% jointly define and monitor improvement plans with suppliers. The study was conducted by Forrester Consulting on behalf of spend management software provider Ivalua.
- Fashion and luxury supply chains should adapt to sourcing risks associated with geopolitical and climate uncertainties with actions including simplifying product portfolios, modernizing production systems and diversifying suppliers, according to analysis from Boston Consulting Group.
International Trade and National Security
- President Biden announced an executive order which provides “formal Presidential direction” regarding potential national security risks the Committee on Foreign Investments should consider when reviewing transactions.
- The U.S. Department of Commerce may publish new regulations affecting exports to China for certain types of semiconductors and semiconductor manufacturing equipment, according to unnamed sources in Reuters.
- In support of efforts to strengthen domestic capabilities and reduce reliance on other nations, President Biden announced an executive order to help advance U.S. biotechnology and biomanufacturing innovation and production.
Sustainability and Product Stewardship
- The Biden administration announced the Federal Buy Clean Initiative will prioritize the purchase of construction materials such as steel, concrete, asphalt and glass containing lower levels of emissions associated with their “manufacturing, transportation, installation, maintenance and disposal.”
Disclaimer
This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.
Author(s)
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.